Soleus Capital Management, L.P. Sarepta Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $5.8 Million - $8.25 Million	-46,166 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$127.12 - $172.34 $1.48 Million - $2.01 Million	11,666 Added 33.81%	46,166 $6.48 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $3.21 Million - $5.92 Million	34,500 New	34,500 $5.53 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.